Review



vancomycin  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    MedChemExpress vancomycin
    Vancomycin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vancomycin/product/MedChemExpress
    Average 95 stars, based on 77 article reviews
    vancomycin - by Bioz Stars, 2026-02
    95/100 stars

    Images



    Similar Products

    vancomycin  (MedChemExpress)
    95
    MedChemExpress vancomycin
    Vancomycin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vancomycin/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    vancomycin - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    vancomycin hy b0671  (MedChemExpress)
    95
    MedChemExpress vancomycin hy b0671
    Vancomycin Hy B0671, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vancomycin hy b0671/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    vancomycin hy b0671 - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    linezolid lzd  (MedChemExpress)
    95
    MedChemExpress linezolid lzd
    Planktonic cells of MSSA SA113 (A) and MRSA YUSA145 (B) were treated with 1/16×, 1/8×, 1/4×, 1/2×, 1× MIC of LLY-507. The LLY-507 MIC for these S. aureus clinical isolates was 25 μM. The OD 600 of the bacterial cells was then measured by Bioscreen C (Turku, Finland) at 1-h intervals for 24 h. TSB without antimicrobials was used as the untreated control. Data are shown as mean ± SD, n = 3. Time-killing curve of LLY-507 against clinical MRSA (YUSA145) and the impact of LLY-507 on the growth curves of S. aureus planktonic cells. Bacterial cultures in the logarithmic growth phase (OD 600 = 0.6–0.8) were treated with 2× MIC of LLY-507, Vancomycin (Van), and <t>Linezolid</t> <t>(LZD)</t> separately (C). Bacterial cultures in the stationary phase (OD 600 > 3) were treated with 2× MIC of LLY-507, Vancomycin, and Linezolid, followed by overnight incubation (D). Bactericidal curves were plotted accordingly.
    Linezolid Lzd, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/linezolid lzd/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    linezolid lzd - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    hy b0671  (MedChemExpress)
    95
    MedChemExpress hy b0671
    Planktonic cells of MSSA SA113 (A) and MRSA YUSA145 (B) were treated with 1/16×, 1/8×, 1/4×, 1/2×, 1× MIC of LLY-507. The LLY-507 MIC for these S. aureus clinical isolates was 25 μM. The OD 600 of the bacterial cells was then measured by Bioscreen C (Turku, Finland) at 1-h intervals for 24 h. TSB without antimicrobials was used as the untreated control. Data are shown as mean ± SD, n = 3. Time-killing curve of LLY-507 against clinical MRSA (YUSA145) and the impact of LLY-507 on the growth curves of S. aureus planktonic cells. Bacterial cultures in the logarithmic growth phase (OD 600 = 0.6–0.8) were treated with 2× MIC of LLY-507, Vancomycin (Van), and <t>Linezolid</t> <t>(LZD)</t> separately (C). Bacterial cultures in the stationary phase (OD 600 > 3) were treated with 2× MIC of LLY-507, Vancomycin, and Linezolid, followed by overnight incubation (D). Bactericidal curves were plotted accordingly.
    Hy B0671, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hy b0671/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    hy b0671 - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    hy b0671 ampicillin medchemexpress  (MedChemExpress)
    95
    MedChemExpress hy b0671 ampicillin medchemexpress
    Planktonic cells of MSSA SA113 (A) and MRSA YUSA145 (B) were treated with 1/16×, 1/8×, 1/4×, 1/2×, 1× MIC of LLY-507. The LLY-507 MIC for these S. aureus clinical isolates was 25 μM. The OD 600 of the bacterial cells was then measured by Bioscreen C (Turku, Finland) at 1-h intervals for 24 h. TSB without antimicrobials was used as the untreated control. Data are shown as mean ± SD, n = 3. Time-killing curve of LLY-507 against clinical MRSA (YUSA145) and the impact of LLY-507 on the growth curves of S. aureus planktonic cells. Bacterial cultures in the logarithmic growth phase (OD 600 = 0.6–0.8) were treated with 2× MIC of LLY-507, Vancomycin (Van), and <t>Linezolid</t> <t>(LZD)</t> separately (C). Bacterial cultures in the stationary phase (OD 600 > 3) were treated with 2× MIC of LLY-507, Vancomycin, and Linezolid, followed by overnight incubation (D). Bactericidal curves were plotted accordingly.
    Hy B0671 Ampicillin Medchemexpress, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hy b0671 ampicillin medchemexpress/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    hy b0671 ampicillin medchemexpress - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Planktonic cells of MSSA SA113 (A) and MRSA YUSA145 (B) were treated with 1/16×, 1/8×, 1/4×, 1/2×, 1× MIC of LLY-507. The LLY-507 MIC for these S. aureus clinical isolates was 25 μM. The OD 600 of the bacterial cells was then measured by Bioscreen C (Turku, Finland) at 1-h intervals for 24 h. TSB without antimicrobials was used as the untreated control. Data are shown as mean ± SD, n = 3. Time-killing curve of LLY-507 against clinical MRSA (YUSA145) and the impact of LLY-507 on the growth curves of S. aureus planktonic cells. Bacterial cultures in the logarithmic growth phase (OD 600 = 0.6–0.8) were treated with 2× MIC of LLY-507, Vancomycin (Van), and Linezolid (LZD) separately (C). Bacterial cultures in the stationary phase (OD 600 > 3) were treated with 2× MIC of LLY-507, Vancomycin, and Linezolid, followed by overnight incubation (D). Bactericidal curves were plotted accordingly.

    Journal: ACS Omega

    Article Title: Inhibition of Growth and Biofilm Formation in Staphylococcus aureus by LLY-507

    doi: 10.1021/acsomega.5c10668

    Figure Lengend Snippet: Planktonic cells of MSSA SA113 (A) and MRSA YUSA145 (B) were treated with 1/16×, 1/8×, 1/4×, 1/2×, 1× MIC of LLY-507. The LLY-507 MIC for these S. aureus clinical isolates was 25 μM. The OD 600 of the bacterial cells was then measured by Bioscreen C (Turku, Finland) at 1-h intervals for 24 h. TSB without antimicrobials was used as the untreated control. Data are shown as mean ± SD, n = 3. Time-killing curve of LLY-507 against clinical MRSA (YUSA145) and the impact of LLY-507 on the growth curves of S. aureus planktonic cells. Bacterial cultures in the logarithmic growth phase (OD 600 = 0.6–0.8) were treated with 2× MIC of LLY-507, Vancomycin (Van), and Linezolid (LZD) separately (C). Bacterial cultures in the stationary phase (OD 600 > 3) were treated with 2× MIC of LLY-507, Vancomycin, and Linezolid, followed by overnight incubation (D). Bactericidal curves were plotted accordingly.

    Article Snippet: Antibiotics LLY-507, Vancomycin (Van), and Linezolid (LZD) were bought from MCE.

    Techniques: Control, Incubation